Gall Matthew

CIK 00018161942 companiesBERKELEY HEIGHTS, NJ

SEC Profile

Transactions

Companies

Filings

CIK

0001816194

Recent Transactions

22 trades

Award
Kalaris Therapeutics, Inc.$KLRS
Stock Option (Right to Buy)
2026-03-19+95,000→ 95,000 total
Award
Kalaris Therapeutics, Inc.$KLRS
Stock Option (Right to Buy)
2025-11-03+235,000→ 235,000 total
Disposition to Issuer
iTeos Therapeutics, Inc.
Stock Option (Right to Buy)
2025-08-29−42,388→ 0 total
Disposition to Issuer
iTeos Therapeutics, Inc.
Stock Option (Right to Buy)
2025-08-29−9,063→ 0 total
Disposition to Issuer
iTeos Therapeutics, Inc.
Stock Option (Right to Buy)
2025-08-29−135,937→ 0 total
Disposition to Issuer
iTeos Therapeutics, Inc.
Stock Option (Right to Buy)
2025-08-29−252,135→ 0 total
Disposition to Issuer
iTeos Therapeutics, Inc.
Stock Option (Right to Buy)
2025-08-29−8,123→ 0 total
Disposition from Tender
iTeos Therapeutics, Inc.
Common Stock
2025-08-29−89,429→ 0 total
Award
iTeos Therapeutics, Inc.
Common Stock
2025-03-07+24,000→ 89,429 total
Award
iTeos Therapeutics, Inc.
Stock Option (Right to Buy)
2025-03-07+145,000→ 145,000 total
Purchase
iTeos Therapeutics, Inc.
Common Stock
2024-11-19$7.73/sh+5,000→ 65,429 total
Award
iTeos Therapeutics, Inc.
Stock Option (Right to Buy)
2024-03-07+163,200→ 163,200 total
Award
iTeos Therapeutics, Inc.
Common Stock
2023-12-05+41,000→ 60,429 total
Purchase
iTeos Therapeutics, Inc.
Common Stock
2023-10-12$8.37/sh+5,000→ 19,429 total
Award
iTeos Therapeutics, Inc.
Stock Option (Right to Buy)
2023-03-09+130,000→ 130,000 total
Award
iTeos Therapeutics, Inc.
Stock Option (Right to Buy)
2022-03-11+85,000→ 85,000 total
Sale
iTeos Therapeutics, Inc.
Common Stock
2021-12-27$46.45/sh−5,000→ 14,429 total
Exercise/Conversion
iTeos Therapeutics, Inc.
Stock Option (right to buy)
2021-10-11−14,429→ 42,388 total
Exercise/Conversion
iTeos Therapeutics, Inc.
Common Stock
2021-10-11$6.16/sh+14,429→ 19,429 total
Award
iTeos Therapeutics, Inc.
Stock Option (Right to Buy)
2021-06-24+24,000→ 24,000 total
Purchase
iTeos Therapeutics, Inc.
Common Stock
2021-06-16$26.09/sh+5,000→ 5,000 total
Award
iTeos Therapeutics, Inc.
Stock Option (Right to Buy)
2021-03-01+72,000→ 72,000 total

Companies

Recent Filings

Address

C/O KALARIS THERAPEUTICS, INC. 400 CONNELL DRIVE, SUITE 5500

BERKELEY HEIGHTS, NJ, 07922

View on SEC.gov